Tirzepatide is a novel dual receptor agonist that targets both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. This pharmaceutical grade peptide is supplied in high purity tirzepatide pens format for research applications.
The compound demonstrates significant potential in metabolic research, particularly in studies related to type 2 diabetes and weight management. As a dual agonist, tirzepatide pens offer researchers a unique tool to investigate the combined effects of GLP-1 and GIP receptor activation.
Our tirzepatide pens are manufactured under strict GMP conditions, ensuring consistent quality and purity for research applications. The lyophilized powder form provides excellent stability and convenient handling for laboratory use.
Key research applications include studies on glucose metabolism, insulin secretion, gastric emptying, and appetite regulation. The compound's unique mechanism of action makes tirzepatide pens valuable for investigating new approaches to metabolic disorders.